HealthTree University: Know Your Therapy - All About ELREXFIO (elranatamab)
ELREXFIO (elranatamab) is the a new approved bispecific antibody for myeloma patients. It works by attracting the innate immune system to come and kill the myeloma cells. In the video below you can find out and see exactly how ELREXFIO works. You can learn about the side effects and how to manage them. Additionally you can see how it is administered and the dosing schedule. Learn more about myeloma treatment at HealthTree University.
12.21 All About ELREXFIO (elranatamab)
We’d like to thank our faculty who donated their time in creating these videos, including:
-
Ajay Nooka, MD, MPH, FACP | Winship Cancer Institute of Emory University
Want more?
We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!
- Myeloma Basics Part 1
- Myeloma Basics Part 2
- Myeloma Basics Part 3
- Myeloma Care Basics
- Building Your Healthcare Team
- Becoming an Empowered Patient
- Starting Myeloma Treatment
- Know Your Therapy
- Know Your Labs: Blood and Urine Testing in Myeloma
- Autologous Stem Cell Transplant (ASCT)
- Precursor Conditions
- Relapsed and Refractory MM Treatment
- Classes of Drugs
- Immunotherapy
- Myeloma Bone Disease
- Imaging in Myeloma
- MRD Testing
- Basic Genetics and Cancer Biology
- Myeloma Genetics
- Types of Genetic Testing in Myeloma
- Specific Myeloma Genetics Mutations and Risk
- Precision Medicine
- Financial Advice for Myeloma Patients and Their Families
- Geriatric Care and Myeloma
- Myeloma Kidney Disease
- Amyloidosis
- Myeloma Basics (Spanish)
- COVID-19 and Multiple Myeloma
- Complementary and Integrated Therapy
- Allogeneic Stem Cell Transplant
- Survivorship
- Clinical Trials
- Understanding Basic Blood tests
- Myeloma Vaccines
